The Valley Desk

ArticleClinical lymphoma, myeloma & leukemiaPublished

Real-World Treatment Patterns and Outcomes for Patients With Relapsed/Refractory Multiple Myeloma and Prior Exposure to Lenalidomide and Proteasome Inhibitors in the United States

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Aged; Aged, 80 and over; Middle Aged; United States; Female; Male; Proteasome Inhibitors
PubMed ID
42135141
Added to directory
Source checked

Report a correction or request removal